Highlights from the journal CHEST^®, September 2022

September 12, 2022

Glenview, Illinois – Published monthly, the journal CHEST^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The September issue of CHEST journal contains 40 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“With September serving as pulmonary fibrosis awareness month, I recommend reading original research such as “Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis,” published in the September issue, which finds that rural participants with idiopathic pulmonary fibrosis present with worse disease severity compared with their suburban counterparts,” says Editor in Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “Lung diseases like pulmonary fibrosis and more in the fields of pulmonary, critical care and sleep medicine will be covered extensively at the upcoming CHEST Annual Meeting in Nashville, Oct. 16-19. The journal CHEST will publish all presented abstracts 1 week before the conference begins, and authors will speak to the research live at the meeting.”

Also included in the current issue of the journal CHEST:

• Asthma
  Original research, “Asthma Control, Airway Mucus, and ¹²⁹Xe MRI Ventilation After a Single Benralizumab Dose,” finds that improved airway function can be measured directly after a first benralizumab dose and that the presence of airway mucus could influence this potential response.
• Critical Care
  Nationwide study, “Factors Associated With Spontaneous Awakening Trial and SpontaneousBreathing Trial Performance in Adults With Critical Illness,” demonstrates that nonmodifiable (age, admitting ICU diagnosis and BMI) and modifiable (ICU symptoms, physical restraint use, use of a target sedation level, etc.) factors influence spontaneous awakening trial and spontaneous breathing trial performance. A visual abstract for the research can be viewed here.

• Sleep
  A state-of-the-art review, “Sex and Gender in Lung Disease and Sleep Disorders,” provides a look into specific effects of sex and gender focused on epidemiology, disease presentation, risk factors and management of lung diseases.

• Thoracic Oncology
  “The Association of Health Care System Resources With Lung CancerScreening Implementation" indicates that policies that increase system-level resources within the Veterans Health Administration could improve lung cancer screening reach and sustainability. An animation of this research can be viewed here.

To view the entire September issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on Twitter for the latest journal news.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.